drugset / Trial / NCT06118827
A Study of HS-10518 in Healthy Female Participants
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HS-10518 in healthy adult premenopausal females in China.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2024-05-30
- Completion
- 2024-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10518 | Unknown | — | Oral |